세계의 경피 패치 시장 : 유통 채널, 용도, 최종사용자, 패치 유형, 접착제 유형, 국가별(16개국 이상) 분석과 예측(2023-2033년)

Global Transdermal Patches Market: Focus on Distribution Channel, Application, End User, Patch Type, Adhesive Type, and Over 16 Countries´ Data - Analysis and Forecast, 2023-2033

US $ 2,475 ￦ 3,395,000

PDF and Excel (1-3 User License)

PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 3,825 ￦ 5,248,000

PDF and Excel (Global License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

경피 패치 시장은 세계의 고령자 인구 증가와 고혈압, 당뇨병, 통증 관련 질환 등 만성질환의 유병률 상승을 배경으로 대폭적인 성장을 보이고 있습니다.

접착제의 개량, 조제의 강화, 새로운 딜리버리 메커니즘 등 패치 기술의 진보도 시장 확대를 한층 더 지원하고 있습니다.

세계의 경피 패치 시장을 조사했으며, 시장 배경·개요, 시장 성장에 대한 각종 영향요인 분석, R&D·특허의 동향, 법규제 환경, 사용 사례, 시장 규모의 추이·예측, 각종 구분·주요 국가별 상세 분석, 경쟁 구도, 주요 기업의 분석 등을 정리하여 전해드립니다.

목차

제1장 시장

• 동향 : 현재 및 향후 영향 평가
• 공급망의 개요
  • 밸류체인 분석
  • 마켓 맵
  • 원재료·부품의 가격 예측
• R&D 리뷰
  • 특허 출원 동향 : 국가·기업별
• 규제 상황
• 이해관계자 분석
  • 사용 사례
  • 최종사용자와 구입 기준
• 주요 세계 이벤트의 영향 분석 : COVID-19·러시아/우크라이나·중동 위기
• 시장 역학의 개요
  • 시장 촉진요인
  • 시장 억제요인
  • 시장 기회

제2장 용도

• 용도 세분화
• 용도의 개요
• 세계의 경피 패치 시장 : 용도별
  • 통증 관리
  • 호르몬 적용
  • 중추신경계 질환
  • 심혈관질환
  • 금연
  • 기타 용도
• 세계의 경피 패치 시장 : 유통 채널별
  • 병원 약국
  • 소매 약국
  • 온라인 약국
• 세계의 경피 패치 시장 : 최종사용자별
  • 홈케어
  • 병원·클리닉

제3장 제품

• 제품 세분화
• 제품 개요
• 세계의 경피 패치 시장
  • 시장 개요
• 세계의 경피 패치 시장 : 패치 유형별
  • 드러그 인 접착제
  • 매트릭스 패치
  • 리저버막 패치
  • 마이크로니들 패치
  • 증기 패치
• 세계의 경피 패치 시장 : 접착제 유형별
  • 아크릴계 접착제
  • 실리콘 접착제
  • 하이드로겔 접착제
  • 기타 접착제

제4장 지역

• 지역 개요
• 촉진요인·억제요인
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제5장 시장 : 경쟁 벤치마킹·기업 개요

• 다음 프론티어
• 지역적 평가
  • Abbvie
  • AdhexPharma
  • Agile Therapeutics
  • Booehringer Ingelheim International GmbH
  • Corium, Inc.
  • Endo Pharmaceuticals Inc.
  • GSK Plc.
  • Himamatsu Pharmaceuticals Co. Ltd.
  • Johnson & Johnson
  • Nitto Denko
  • Novartis AG
  • Optum Rx
  • Prosolus, Inc.
  • Teva Pharmaceuticals
  • Viatris

제6장 조사 방법

KSA

영문 목차

영문목차

“Global Transdermal Patches Market Poised for Robust Growth.”

Introduction to Global Transdermal Patches Market

The transdermal patches market encompasses a dynamic sector within the pharmaceutical industry that focuses on the development, manufacturing, and distribution of patches designed for drug delivery through the skin. These patches offer a non-invasive and convenient alternative to traditional routes of drug administration. Utilizing the skin as a medium for drug absorption, these patches steadily release medication into the bloodstream, ensuring controlled dosing and prolonged therapeutic effects.

The market is witnessing substantial growth owing to the rising prevalence of chronic diseases like hypertension, diabetes, and pain-related conditions, along with an increasing elderly population globally. Advancements in patch technology, including improved adhesives, enhanced drug formulations, and novel delivery mechanisms, are further propelling market expansion.

Market Segmentation:

Segmentation 1: by Application

• Pain Management
• Hormonal Application
• Central Nervous System Disorders
• Cardiovascular Diseases
• Smoking Cessation
• Other Application

Segmentation 2: by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Segmentation 3: by End-User

• Homecare Settings
• Hospitals & Clinics

Segmentation 4: by Patch Type

• Drug-In-Adhesive
• Matrix Patches
• Reservoir Membrane Patches
• Microneedle Patches
• Vapour Patches

Segmentation 5: by Adhesive Type

• Acrylic Adhesives
• Silicone Adhesives
• Hydrogel Adhesives
• Other Adhesives

Segmentation 6: by Region

• North America
• Europe
• Asia-Pacific
• Rest-of-the-World (ROW)

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names in this market are:

Key Questions to be Answered:

• How big is the transdermal patches market?
• What are the major drivers, challenges, and opportunities of the global transdermal patches market?
• Who are the key players in the transdermal patches market?
• Which is the fastest growing region in transdermal patches market?
• Which region has the largest share in the transdermal patches market?

Table of Contents

1 Markets

• 1.1 Trends : Current and Future Impact Assessment
  • 1.1.1 Sample Text
  • 1.1.2 Trend 1
  • 1.1.3 Trend 2
  • 1.1.4 Trend 3
• 1.2 Supply chain Overview
  • 1.2.1 Value Chain Analysis
  • 1.2.2 Market Map
  • 1.1.1 Pricing Forecast for Raw Materials and Components
• 1.3 Research and Development Review
  • 1.3.1 Patent Filing Trend (by Country, Company)
• 1.4 Regulatory Landscape
• 1.5 Stakeholder Analysis
  • 1.5.1 Use case
  • 1.5.2 End User and Buying Criteria
• 1.6 Impact Analysis for Key Global Events- Covid19, Russia/Ukraine or Middle East Crisis
• 1.7 Market Dynamics Overview
  • 1.7.1 Market Drivers
  • 1.7.2 Market Restraints
  • 1.7.3 Market Opportunities

2 Application

• 2.1 Application Segmentation
• 2.2 Application Summary
• 2.3 Global Transdermal Patches Market (by Application)
  • 2.3.1 Pain Management
  • 2.3.2 Hormonal Application
    • 2.3.2.1 Transdermal Testosterone Therapy
    • 2.3.2.2 Transdermal Oestrogen Therapy
  • 2.3.3 Central Nervous System Disorders
  • 2.3.4 Cardiovascular Diseases
  • 2.3.5 Smoking Cessation
  • 2.3.6 Other Application
• 2.4 Global Transdermal Patches Market (by Distribution Channel)
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Retail Pharmacies
  • 2.4.3 Online Pharmacies
• 2.5 Global Transdermal Patches Market (by End-User)
  • 2.5.1 Homecare Settings
  • 2.5.2 Hospitals & Clinics

3 Products

• 3.1 Product Segmentation
• 3.2 Product Summary
• 3.3 Global Transdermal Patches Market
  • 3.3.1 Market Overview
    • 3.3.1.1 Analyst View
• 3.4 Global Transdermal Patches Market (by Patch Type)
  • 3.4.1 Drug-In-Adhesive
    • 3.4.1.1 Single Layer Drug in Adhesive Patch
    • 3.4.1.2 Multi-Layer Drug in Adhesive Patch
  • 3.4.2 Matrix Patches
  • 3.4.3 Reservoir Membrane Patches
  • 3.4.4 Microneedle Patches
  • 3.4.5 Vapour Patches
• 3.5 Global Transdermal Patches Market (By Adhesive Type)
  • 3.5.1 Acrylic Adhesives
  • 3.5.2 Silicone Adhesives
  • 3.5.3 Hydrogel Adhesives
  • 3.5.4 Other Adhesives

4 Regions

• 4.1 Regional Summary
• 4.2 Drivers and Restraints
• 4.3 North America
  • 4.3.1 Regional Overview
  • 4.3.2 Driving Factors for Market Growth
  • 4.3.3 Factors Challenging the Market
  • 4.3.4 Application
  • 4.3.5 Product
  • 4.3.6 U.S.
  • 4.3.7 U.S. Transdermal Patches Market by Application
  • 4.3.8 Canada
  • 4.3.9 Canada Transdermal Patches Market by Application
• 4.4 Europe
  • 4.4.1 Regional Overview
  • 4.4.2 Driving Factors for Market Growth
  • 4.4.3 Factors Challenging the Market
  • 4.4.4 Application
  • 4.4.5 Product
  • 4.4.6 France
  • 4.4.7 France Transdermal Patches Market by Application
  • 4.4.8 Germany
  • 4.4.9 Germany Transdermal Patches Market by Application
  • 4.4.10 U.K.
  • 4.4.11 U.K. Transdermal Patches Market by Application
  • 4.4.12 Rest of Europe
  • 4.4.13 Rest of Europe Transdermal Patches Market by Application
• 4.5 Asia Pacific
  • 4.5.1 Regional Overview
  • 4.5.2 Driving Factors for Market Growth
  • 4.5.3 Factors Challenging the Market
  • 4.5.4 Application
  • 4.5.5 Product
  • 4.5.6 China
  • 4.5.7 China Transdermal Patches Market by Application
  • 4.5.8 India
  • 4.5.9 India Transdermal Patches Market by Application
  • 4.5.10 Japan
  • 4.5.11 Japan Transdermal Patches Market by Application
  • 4.5.12 Rest-of-Asia-Pacific
  • 4.5.13 Rest-of-Asia-Pacific Transdermal Patches Market by Application
• 4.6 Rest-of-the-World
  • 4.6.1 Regional Overview
  • 4.6.2 Driving Factors for Market Growth
  • 4.6.3 Factors Challenging the Market
  • 4.6.4 Application
  • 4.6.5 Product
  • 4.6.6 The Middle East and Africa
  • 4.6.7 The Middle East and Africa Transdermal Patches Market by Application
  • 4.6.8 Latin America
  • 4.6.9 Latin America Transdermal Patches Market by Application

5 Markets - Competitive Benchmarking & Company Profiles

• 5.1 Next Frontiers…..
• 5.2 Geographic Assessment
  • 5.2.1 Abbvie
    • 5.2.1.1 Overview
    • 5.2.1.2 Top Products / Product Portfolio
    • 5.2.1.3 Top Competitors
    • 5.2.1.4 Target Customers
    • 5.2.1.5 Key Personnel
    • 5.2.1.6 Analyst View
    • 5.2.1.7 Market Share
  • 5.2.2 AdhexPharma
    • 5.2.2.1 Overview
    • 5.2.2.2 Top Products / Product Portfolio
    • 5.2.2.3 Top Competitors
    • 5.2.2.4 Target Customers
    • 5.2.2.5 Key Personnel
    • 5.2.2.6 Analyst View
    • 5.2.2.7 Market Share
  • 5.2.3 Agile Therapeutics
    • 5.2.3.1 Overview
    • 5.2.3.2 Top Products / Product Portfolio
    • 5.2.3.3 Top Competitors
    • 5.2.3.4 Target Customers
    • 5.2.3.5 Key Personnel
    • 5.2.3.6 Analyst View
    • 5.2.3.7 Market Share
  • 5.2.4 Booehringer Ingelheim International GmbH
    • 5.2.4.1 Overview
    • 5.2.4.2 Top Products / Product Portfolio
    • 5.2.4.3 Top Competitors
    • 5.2.4.4 Target Customers
    • 5.2.4.5 Key Personnel
    • 5.2.4.6 Analyst View
    • 5.2.4.7 Market Share
  • 5.2.5 Corium, Inc.
    • 5.2.5.1 Overview
    • 5.2.5.2 Top Products / Product Portfolio
    • 5.2.5.3 Top Competitors
    • 5.2.5.4 Target Customers
    • 5.2.5.5 Key Personnel
    • 5.2.5.6 Analyst View
    • 5.2.5.7 Market Share
  • 5.2.6 Endo Pharmaceuticals Inc.
    • 5.2.6.1 Overview
    • 5.2.6.2 Top Products / Product Portfolio
    • 5.2.6.3 Top Competitors
    • 5.2.6.4 Target Customers
    • 5.2.6.5 Key Personnel
    • 5.2.6.6 Analyst View
    • 5.2.6.7 Market Share
  • 5.2.7 GSK Plc.
    • 5.2.7.1 Overview
    • 5.2.7.2 Top Products / Product Portfolio
    • 5.2.7.3 Top Competitors
    • 5.2.7.4 Target Customers
    • 5.2.7.5 Key Personnel
    • 5.2.7.6 Analyst View
    • 5.2.7.7 Market Share
  • 5.2.8 Himamatsu Pharmaceuticals Co. Ltd.
    • 5.2.8.1 Overview
    • 5.2.8.2 Top Products / Product Portfolio
    • 5.2.8.3 Top Competitors
    • 5.2.8.4 Target Customers
    • 5.2.8.5 Key Personnel
    • 5.2.8.6 Analyst View
    • 5.2.8.7 Market Share
  • 5.2.9 Johnson & Johnson
    • 5.2.9.1 Overview
    • 5.2.9.2 Top Products / Product Portfolio
    • 5.2.9.3 Top Competitors
    • 5.2.9.4 Target Customers
    • 5.2.9.5 Key Personnel
    • 5.2.9.6 Analyst View
    • 5.2.9.7 Market Share
  • 5.2.10 Nitto Denko
    • 5.2.10.1 Overview
    • 5.2.10.2 Top Products / Product Portfolio
    • 5.2.10.3 Top Competitors
    • 5.2.10.4 Target Customers
    • 5.2.10.5 Key Personnel
    • 5.2.10.6 Analyst View
    • 5.2.10.7 Market Share
  • 5.2.11 Novartis AG
    • 5.2.11.1 Overview
    • 5.2.11.2 Top Products / Product Portfolio
    • 5.2.11.3 Top Competitors
    • 5.2.11.4 Target Customers
    • 5.2.11.5 Key Personnel
    • 5.2.11.6 Analyst View
    • 5.2.11.7 Market Share
  • 5.2.12 Optum Rx
    • 5.2.12.1 Overview
    • 5.2.12.2 Top Products / Product Portfolio
    • 5.2.12.3 Top Competitors
    • 5.2.12.4 Target Customers
    • 5.2.12.5 Key Personnel
    • 5.2.12.6 Analyst View
    • 5.2.12.7 Market Share
  • 5.2.13 Prosolus, Inc.
    • 5.2.13.1 Overview
    • 5.2.13.2 Top Products / Product Portfolio
    • 5.2.13.3 Top Competitors
    • 5.2.13.4 Target Customers
    • 5.2.13.5 Key Personnel
    • 5.2.13.6 Analyst View
    • 5.2.13.7 Market Share
  • 5.2.14 Teva Pharmaceuticals
    • 5.2.14.1 Overview
    • 5.2.14.2 Top Products / Product Portfolio
    • 5.2.14.3 Top Competitors
    • 5.2.14.4 Target Customers
    • 5.2.14.5 Key Personnel
    • 5.2.14.6 Analyst View
    • 5.2.14.7 Market Share
  • 5.2.15 Viatris
    • 5.2.15.1 Overview
    • 5.2.15.2 Top Products / Product Portfolio
    • 5.2.15.3 Top Competitors
    • 5.2.15.4 Target Customers
    • 5.2.15.5 Key Personnel
    • 5.2.15.6 Analyst View
    • 5.2.15.7 Market Share

6 Research Methodology

• 6.1 Data Sources
  • 6.1.1 Primary Data Sources
  • 6.1.2 Secondary Data Sources
  • 6.1.3 Data Triangulation
• 6.2 Market Estimation and Forecast

관련자료